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One of major study concerns in virology is viral adaptive evolution due to its highly replicable
and mutable nature in changeable environments. Some viruses with this property are severely
pathogenic for animals and also for humans. Virologists thus must prepare the ground for
clinical applications of their findings obtained by structural and functional analyses on viruses.
Among viruses, some coronaviruses (CoVs) are notorious for causing the severe acute respiratory
syndrome (SARS) and Middle East respiratory syndrome (MERS). Markedly, the very now
COVID-19 outbreak is brought about by a new coronavirus designated SARS-CoV-2 (1–3). In this
commentary, we focus on the titled review article and mainly introduce evolutionary aspects of the
coronaviruses. The said article has successfully predicted today’s COVID-19 outbreak by pointing
out that novel pathogenic variants will readily emerge from very diversified severe acute respiratory
syndrome-related coronaviruses (SARSr-CoVs) of the bat origin through their close coexistence
and high genetic recombination ability (Figure 1). Therefore, it is very appropriate and timely to
introduce this excellent review article here in the General Commentary article.
As basal knowledge for coronaviruses, they form an envelope structure at the outer surface of
virions and their morphology is spherical with 100–160 nm in diameter. Their genome is positive-
sense (+) single-stranded (ss) RNA and 27–32 kb in size. Coronaviruses have extra accessory
genes in addition to those for viral structural proteins. Following entry into cells via the specific
interaction of viral envelope glycoprotein spike (S) and cellular receptor, coronaviruses replicate
in the cytoplasm as the other ssRNA (+) viruses. For alpha- and beta-coronaviruses, they are
originated in highly metabolized mammals, such as bats and rodents. After being spilled over to
alpacas, cows, civets, camels, or pigs, they can also infect humans and frequently cause SARS and
MERS. Gamma- and delta-coronaviruses mainly infect birds, but they sometimes infect mammals.
Molecular phylogenetic trees well support this idea of classifications.
Among several genes on the genome of interest, an evolutionary biologist tends to focus on
a functionally conserved but sequentially diverged gene. This is because the role for the critical
gene is conserved in various species, while it is rapidly evolving, indicating that a diverging force
acts on the gene, e.g., by co-evolution such as symbiosis, evolutionary arms race, or others. Of
the CoV genes, this review has centered on structural gene S and extra genes orf3/orf8 that
encode S and accessory proteins, respectively. Importantly, the most frequently observed hotspots
for recombination are within S gene and upstream region of orf8 gene. Orf8 of SARS-CoV is
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FIGURE 1 | Emergence of coronaviruses pathogenic for humans from ancestral bat viruses. Diversification of SARS-CoV, SARS-CoV-2, and MERS-CoV from
ancestor viruses by possible genome recombinations is illustrated. Two major variable regions among viral genomes (S and orf8 genes) are indicated. The variations
are most probably due to the high recombination potentials of the coronaviruses. For details, refer to the titled review article in this commentary.
assumed to be acquired from SARSr-CoV by recombination,
and is positively selected (4). S protein contains the receptor-
binding domain (RBD) critical for infection, and ORF3/ORF8
proteins function viral species-specifically, e.g., by prescribing
the virulence (ORF8), anti-interferon activity (ORF3/ORF8)
or others. Because ORF3/ORF8 are different between SARS-
CoV and SARS-CoV-2, they might contribute to the difference
in their virulence (5). Additionally, S and orf3 genes are
positively selected in civet SARSr-CoVs (4). Since RNA viruses
are easy to mutate and coronaviruses have high potentials for
recombination, we can easily see the track of mutations and
evolutions of the viruses, especially for SARS-CoV and MERS-
CoV. RNA recombination by RNA-dependent RNA polymerase
with a low fidelity is widely observed and is supposed to shape
current viruses by rearranging their genomes or disseminating
functional modules (6). For coronaviruses such as mouse
hepatitis virus (MHV), secondary structures of RNA genome are
responsible for highly dynamic spike structures (7). These might
be an evolutionary cradle from “RNA world,” still function in the
living organisms nowadays. The non-processive replicase-driven
template switching mechanism proposed among coronaviruses
(8) thus is a suitable model for the evolution of RNA-
based replicating system. Among many viruses, coronaviruses
(recombination frequency for the total genome in vivo is 25%)
and picornaviruses are champions of the RNA recombination
frequency (8).
Let us move to the evolution of coronaviruses (Figure 1).
In detail for each gene of the viruses noticed, orf8 is well-
known for viral evolution and the accompanied increase of
virulence observed during the late onset of SARS. For the
RBD in S, SARS-CoV utilizes ACE2 as a cellular receptor
for infection, and MERS-CoV utilizes DPP4 as the receptor.
The receptor recognition is important for infection process
for the viruses. Different use of the receptors among the
coronaviruses is due to their sequences/structures of RBD.
Nonetheless, because of the common nature of RBD (9), it
can be a promising target for development of novel antiviral
compounds and antibody therapies for these viruses. However,
it is also true in some cases, viruses went beyond the arms
race and ingeniously evolved to counteract the clinical strategy.
For example, the strategy is applicable for SARS-CoV WIV1
strain but not for SHC014 and HKU3. HKU3 is remarkable
for its truncated form of RBD. For MERS-CoV, cells expressing
suboptimal bat species-derived variant of DPP4 force the viruses
to accumulate mutations in the viral spike during passages,
resulting in enhanced viral entry merely with two amino acid
mutations (10). The type of adaptation phenomena in virus
evolution is testable either in clinical medicine or in vitro
evolution system.
Thus, to consider the origin of new pathogens and the
prevention of their transmission to humans, and control of the
viruses, not only studies on SARS-CoV, MERS-CoV, and SARS-
CoV-2, but also those on their relatives SARSr-CoVs andMERSr-
CoVs are recommendable for bats tracked for the ecology and
evolution. We better understand the interaction networks among
viruses of the evolution and diversification by their detailed
comparison (Figure 1). The review mentions Yunnan SARSr-
CoVs might be the origins of the SARS-CoVs, as symbionts,
while domestication activity for mammals affects acquisition of
pathogenicity to humans [refer also to Banerjee et al. (11)]. Both
fieldworks and experimental biology are required to understand
the viruses concomitantly with predicting or preventing
potential outbreaks.
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